Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 (BOSTON II)

Clinical Trial ID NCT02303366

PubWeight™ 5.28‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02303366

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat Rev Clin Oncol 2015 1.22
2 Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 2016 1.18
3 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
4 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
5 Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond. Ther Adv Med Oncol 2016 0.77
6 Future perspectives in cancer immunotherapy. Ann Transl Med 2016 0.77
Next 100